Associations of moderate alcohol consumption with clinical and MRI measures in multiple sclerosis

Journal of Neuroimmunology

Volumn 243, Issue 1-2, 2012, Pages 61-68

  Foster, Mathew ^a   Zivadinov, Robert ^b   Weinstock Guttman, Bianca ^b   Tamaño Blanco, Miriam ^a   Badgett, Darlene ^a   Carl, Ellen ^b   Ramanathan, Murali ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Alcohol; Disability; Environmental factors; Ethanol; MRI; Multiple sclerosis; Progression

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ALCOHOLIC BEVERAGE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; DISABILITY; DISEASE ASSOCIATION; DISEASE DURATION; ENVIRONMENTAL FACTOR; EXPANDED DISABILITY STATUS SCALE; FEMALE; GENETIC RISK; GRAY MATTER; HUMAN; IMAGE ANALYSIS; IMAGE ENHANCEMENT; LATERAL BRAIN VENTRICLE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PARENCHYMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REGRESSION ANALYSIS;

ADULT; ALCOHOL DRINKING; ATROPHY; BRAIN; DISABILITY EVALUATION; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; REGRESSION ANALYSIS; SEASONS; SEVERITY OF ILLNESS INDEX;

EID: 84856955666     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.12.007     Document Type: Article

References (44)

1. Albensi B.C. Potential roles for tumor necrosis factor and nuclear factor-kappaB in seizure activity. J. Neurosci. Res. 2001, 66:151-154.
2. Albensi B.C., Mattson M.P. Evidence for the involvement of TNF and NF-kappaB in hippocampal synaptic plasticity. Synapse 2000, 35:151-159.
3. Arriola L., Martinez-Camblor P., Larranaga N., Basterretxea M., Amiano P., Moreno-Iribas C., Carracedo R., Agudo A., Ardanaz E., Barricarte A., Buckland G., Cirera L., Chirlaque M.D., Martinez C., Molina E., Navarro C., Quiros J.R., Rodriguez L., Sanchez M.J., Tormo M.J., Gonzalez C.A., Dorronsoro M. Alcohol intake and the risk of coronary heart disease in the Spanish EPIC cohort study. Heart 2010, 96:124-130.
4. Barve S.S., Kelkar S.V., Gobejishvilli L., Joshi-Barve S., McClain C.J. Mechanisms of alcohol-mediated CD4+ T lymphocyte death: relevance to HIV and HCV pathogenesis. Front. Biosci. 2002, 7:d1689-d1696.
5. Bertiere M.C., Betoulle D., Apfelbaum M., Girard-Globa A. Time-course, magnitude and nature of the changes induced in HDL by moderate alcohol intake in young non-drinking males. Atherosclerosis 1986, 61:7-14.
6. Clapp P., Bhave S.V., Hoffman P.L. How adaptation of the brain to alcohol leads to dependence: a pharmacological perspective. Alcohol Res. Health 2008, 31:310-339.
7. Cook R.T. Alcohol abuse, alcoholism, and damage to the immune system-a review. Alcohol. Clin. Exp. Res. 1998, 22:1927-1942.
8. Davies M. The role of GABAA receptors in mediating the effects of alcohol in the central nervous system. J. Psychiatry Neurosci. 2003, 28:263-274.
9. Emberson J.R., Bennett D.A. Effect of alcohol on risk of coronary heart disease and stroke: causality, bias, or a bit of both?. Vasc. Health Risk Manage. 2006, 2:239-249.
10. Eskandari F., Sternberg E.M. Neural-immune interactions in health and disease. Ann. N. Y. Acad. Sci. 2002, 966:20-27.
11. Frohman E.M., Racke M.K., Raine C.S. Multiple sclerosis-the plaque and its pathogenesis. N. Engl. J. Med. 2006, 354:942-955.
12. Goral J., Karavitis J., Kovacs E.J. Exposure-dependent effects of ethanol on the innate immune system. Alcohol 2008, 42:237-247.
13. Hawkes C.H. Are multiple sclerosis patients risk-takers?. QJM 2005, 98:895-911.
14. Kovacs E.J., Messingham K.A. Influence of alcohol and gender on immune response. Alcohol Res. Health 2002, 26:257-263.
15. MacGregor R.R., Louria D.B. Alcohol and infection. Curr. Clin. Top. Infect. Dis. 1997, 17:291-315.
16. Mandrekar P., Catalano D., Girouard L., Szabo G. Human monocyte IL-10 production is increased by acute ethanol treatment. Cytokine 1996, 8:567-577.
17. Marrie R.A. Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol. 2004, 3:709-718.
18. Marrie R.A. Multiple sclerosis and risk-taking. QJM 2006, 99:63.
19. Marrie R., Horwitz R., Cutter G., Tyry T., Campagnolo D., Vollmer T. High frequency of adverse health behaviors in multiple sclerosis. Mult. Scler. 2009, 15:105-113.
20. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., McFarland H.F., Paty D.W., Polman C.H., Reingold S.C., Sandberg-Wollheim M., Sibley W., Thompson A., van den Noort S., Weinshenker B.Y., Wolinsky J.S. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 2001, 50:121-127.
21. Meffert M.K., Chang J.M., Wiltgen B.J., Fanselow M.S., Baltimore D. NF-kappa B functions in synaptic signaling and behavior. Nat. Neurosci. 2003, 6:1072-1078.
22. Mihic S.J. Acute effects of ethanol on GABAA and glycine receptor function. Neurochem. Int. 1999, 35:115-123.
23. Neiman J. Alcohol as a risk factor for brain damage: neurologic aspects. Alcohol. Clin. Exp. Res. 1998, 22:346S-351S.
24. Ogilvie K., Lee S., Weiss B., Rivier C. Mechanisms mediating the influence of alcohol on the hypothalamic-pituitary-adrenal axis responses to immune and nonimmune signals. Alcohol. Clin. Exp. Res. 1998, 22:243S-247S.
25. Oscar-Berman M., Shagrin B., Evert D.L., Epstein C. Impairments of brain and behavior: the neurological effects of alcohol. Alcohol Health Res. World 1997, 21:65-75.
26. Paul S.M. Alcohol-sensitive GABA receptors and alcohol antagonists. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:8307-8308.
27. Paunio M., Heinonen O.P., Virtamo J., Klag M.J., Manninen V., Albanes D., Comstock G.W. HDL cholesterol and mortality in Finnish men with special reference to alcohol intake. Circulation 1994, 90:2909-2918.
28. Quesnel S., Feinstein A. Multiple sclerosis and alcohol: a study of problem drinking. Mult. Scler. 2004, 10:197-201.
29. Roxburgh R.H., Seaman S.R., Masterman T., Hensiek A.E., Sawcer S.J., Vukusic S., Achiti I., Confavreux C., Coustans M., Le Page E., Edan G., McDonnell G.V., Hawkins S., Trojano M., Liguori M., Cocco E., Marrosu M.G., Tesser F., Leone M.A., Weber A., Zipp F., Miterski B., Epplen J.T., Oturai A., Sorensen P.S., Celius E.G., Lara N.T., Montalban X., Villoslada P., Silva A.M., Marta M., Leite I., Dubois B., Rubio J., Butzkueven H., Kilpatrick T., Mycko M.P., Selmaj K.W., Rio M.E., Sa M., Salemi G., Savettieri G., Hillert J., Compston D.A. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 2005, 64:1144-1151.
30. Sillanaukee P., Koivula T., Jokela H., Pitkajarvi T., Seppa K. Alcohol consumption and its relation to lipid-based cardiovascular risk factors among middle-aged women: the role of HDL(3) cholesterol. Atherosclerosis 2000, 152:503-510.
31. Smith S.M., Zhang Y., Jenkinson M., Chen J., Matthews P.M., Federico A., De Stefano N. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. NeuroImage 2002, 17:479-489.
32. Sospedra M., Martin R. Immunology of multiple sclerosis. Annu. Rev. Immunol. 2005, 23:683-747.
33. Stone B.M. Sleep and low doses of alcohol. Electroencephalogr. Clin. Neurophysiol. 1980, 48:706-709.
34. Szabo G., Girouard L., Mandrekar P., Catalano D. Acute ethanol treatment augments interleukin-12 production in activated human monocytes. Ann. N. Y. Acad. Sci. 1996, 795:422-425.
35. Testino G. Alcoholic diseases in hepato-gastroenterology: a point of view. Hepatogastroenterology 2008, 55:371-377.
36. Thornton J., Symes C., Heaton K. Moderate alcohol intake reduces bile cholesterol saturation and raises HDL cholesterol. Lancet 1983, 2:819-822.
37. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mork S., Bo L. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 1998, 338:278-285.
38. Vliegenthart R., Oei H.H., van den Elzen A.P., van Rooij F.J., Hofman A., Oudkerk M., Witteman J.C. Alcohol consumption and coronary calcification in a general population. Arch. Intern. Med. 2004, 164:2355-2360.
39. Weinstock-Guttman B., Zivadinov R., Qu J., Cookfair D., Duan X., Bang E., Bergsland N., Hussein S., Cherneva M., Willis L., Heininen-Brown M., Ramanathan M. Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients. J. Neurol. Neurosurg. Psychiatry 2011, 82:189-195.
40. White A.M. What happened? Alcohol, memory blackouts, and the brain. Alcohol Res. Health 2003, 27:186-196.
41. Williams D.L., MacLean A.W., Cairns J. Dose-response effects of ethanol on the sleep of young women. J. Stud. Alcohol 1983, 44:515-523.
42. Wu, Y., Lousberg, E.L., Moldenhauer, L.M., Hayball, J.D., Coller, J.K., Rice, K.C., Watkins, L.R., Somogyi, A.A., Hutchinson, M.R., in press. Inhibiting the TLR4-MyD88 signalling cascade by genetic or pharmacologic strategies reduces acute alcohol dose-induced sedation and motor impairment in mice. Br. J. Pharmacol. doi:. doi:10.1111/j.1476-5381.2011.01572.x.
43. Zivadinov R., Rudick R.A., De Masi R., Nasuelli D., Ukmar M., Pozzi-Mucelli R.S., Grop A., Cazzato G., Zorzon M. Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS. Neurology 2001, 57:1239-1247.
44. Zivadinov R., Weinstock-Guttman B., Benedict R., Tamano-Blanco M., Hussein S., Abdelrahman N., Durfee J., Ramanathan M. Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor. Hum. Mol. Genet. 2007, 16:2659-2668.